Can inhalation of corticosteroids like Forocort (formoterol and budesonide) and Budesonide cause mouth ulcers in patients with respiratory conditions such as asthma or Chronic Obstructive Pulmonary Disease (COPD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Inhaled Corticosteroids and Mouth Ulcer Pain

Inhaled corticosteroids like Forocort (formoterol/budesonide combination) and budesonide do not typically cause mouth ulcers, but they commonly cause oropharyngeal candidiasis (oral thrush) and throat irritation, which can present as mouth and throat pain that may be mistaken for ulcers.

Primary Oral Adverse Effects

The most well-documented oral side effects of inhaled corticosteroids are:

  • Oropharyngeal candidiasis (oral thrush) occurs with increased frequency in patients using inhaled corticosteroids, presenting as white patches in the mouth and throat that can cause pain and discomfort 1.

  • Throat irritation is a common adverse effect reported in clinical trials of inhaled corticosteroids, which can manifest as soreness and pain in the mouth and throat 1.

  • The FDA label for budesonide specifically warns that localized infections with Candida albicans occur in the mouth and pharynx, and these infections may require treatment with antifungal therapy 2.

Distinguishing Features

While true mouth ulcers are not a characteristic side effect:

  • Oral candidiasis appears as redness or white-colored patches in the mouth or throat, which can be painful and may be confused with ulcers 2.

  • The incidence of oral candidiasis is significantly increased with inhaled corticosteroid use (OR 2.65,95% CI 2.03-3.46) according to the American College of Chest Physicians 3.

  • Patients may experience a "sore mouth/throat" as a distinct symptom from candidiasis, which was reported as a common side effect in clinical studies 4.

Risk Mitigation Strategies

The most critical preventive measure is proper mouth rinsing after each use:

  • Patients should rinse their mouth with water and spit it out after each budesonide inhalation treatment to reduce the risk of fungal infections 2.

  • Using large-volume spacers with the inhaler can minimize oral deposition and reduce local side effects 1, 5.

  • Despite guideline recommendations, approximately 30.5% of patients report suboptimal mouth rinsing practices, which increases their risk of oropharyngeal adverse effects 4.

  • Receiving advice from a healthcare professional significantly increases the likelihood of correct mouth rinsing implementation (P < 0.001) 4.

Rare Allergic Reactions

In exceptional cases, true allergic reactions can occur:

  • Severe type IV contact allergy to budesonide has been documented, presenting with angioedema, swelling of the lips and oral cavity, and dysphagia developing 3-4 hours after use 6.

  • Hypersensitivity reactions including rash, contact dermatitis, urticaria, angioedema, and bronchospasm have been reported with budesonide use, though these are uncommon 2.

  • If such allergic reactions occur, budesonide should be discontinued immediately 2.

Clinical Management

If a patient reports mouth pain while using Forocort or budesonide:

  • Examine the oral cavity for white patches or redness consistent with candidiasis rather than true ulceration 2.

  • Verify the patient is rinsing their mouth properly after each use, as this simple intervention prevents most oral complications 2, 4.

  • If candidiasis is present, treat with appropriate local or systemic antifungal therapy while continuing the inhaled corticosteroid if asthma control requires it 2.

  • Consider switching to a different corticosteroid formulation if symptoms persist despite proper technique and treatment, as fluticasone is more likely to cause systemic effects compared to budesonide 7.

  • If true allergic symptoms develop (rapid swelling, severe pain, difficulty swallowing), discontinue the medication immediately and consider alternative corticosteroids from different chemical groups 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Corticosteroides Inhalados en el Manejo de la Influenza

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Implementation of mouth rinsing after use of inhaled corticosteroids in Australia.

International journal of clinical pharmacy, 2021

Guideline

Role of Corticosteroids in COPD Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Systemic effects of inhaled corticosteroids: an overview.

The open respiratory medicine journal, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.